2024年11月12日，科技日报报道了一项令人瞩目的医学突破。日本大阪大学的科学家首次利用人类诱导多能干细胞（iPS细胞）转化而来的角膜组织，成功修复了4名角膜缘干细胞缺乏症（LSCD）患者的角膜。这一创新性的研究不仅为角膜疾病患者带来了新的希望，也 ...

First human trial of stem-cell-derived corneal transplants for LSCD shows vision improvement, suggesting a safe and effective ...

Dr. Roy Rubinfeld, an internationally renowned corneal surgeon and innovator, has developed a groundbreaking epithelium-on ...

Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...

The corneal and conjunctival epithelia and the tear film constitute the ocular surface. The conjunctival epithelium contains mucin-producing goblet cells and the mucosal immune defense system.

Induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency could transform eye care and ...

In early November, researchers at Osaka University in Japan published groundbreaking findings in the scientific journal The ...

ROCKVILLE, MD / ACCESSWIRE / November 26, 2024 / Dr. Roy Rubinfeld, an internationally renowned corneal surgeon and innovator, has developed a groundbreaking epithelium-on corneal cross-linking ...

In a pioneering study, stem-cell-derived corneal implants improve sight for patients with severe vision impairment, offering a potential breakthrough for treating limbal stem cell deficiency.